”Shares in Diasorin surged over 13% on Tuesday after the Italian diagnostic specialist said it had completed the studies to support the launch of a new molecular test to quickly identify the new coronavirus.”
“The test developed by Diasorin enables sample-to-answer results within 60 minutes instead of the 5-7 hours currently needed to report patient results, the company said in a statement.
The new product is expected to be launched in Europe with a CE marking, which certifies the conformity to European standards, and submitted to the Food and Drug Administration (FDA) by the end of March.“
Views: